Navigation Links
Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results
Date:8/19/2010

nts to reconcile net income to cash provided by (used in) operating activities: Bad debt expense (116,962) (196,863) Depreciation 814,376 1,112,849 Amortization 167,147 194,380 Interest expense -- 2,710 Gain on sale of assets (15,085) (15,717) Rental expense borne by a related party 163,532 163,331 (Increase) decrease in assets: Accounts receivable, trade - related parties 6,725,384 (5,532,449) Other receivables (1,349,264) 10,743 Other receivables - related parties 213,304 (992,241) Inventories (421,815) 3,355,993 Employee advances (121,454) (80,805) Prepaid expense 307,795 (435,576) Increase (decrease) in liabilities: Accounts payable (662,699) (1,579,065) Advances from customers - related parties 12,562,625 (219,470) Wages and benefits payable (699,884) (703,898) Other taxes payable 615,431 8,920 Other payables 94,272 (395,970) Other payables - related parties 191,991 (202,847) Net cash provided by operating activities 22,580,159 13,809,193 CASH FLOWS FROM INVESTING ACTIVITIES: Investment in Life Resources 6,000,000 -- Collections from loans to local government -- 105,193 Proceeds from disposal of a subsidiary 700,000 -- Construction deposits (2,678,074) (3,846,961) Contractor deposits 73,959 158,551 Addition to construction in progress (18,790,772) (15,954,182) Equipment deposits (6,133,065) - Proceeds from sales of properties 2,621,558 17,039 Purchase of equipment and automobiles (578,794) (921,388) Net cash used in investing activities (18,785,188) (20,441,748) CASH FLOWS FROM FINANCING ACTIVITIES: Loan from (repayment to) related parties -- (3,945,510) Net cash used in financing activities -- (3,945,510) EFFECT OF EXCHANGE RATE CHANGES ON CASH 17,473 64,084 NET INCREASE (DECREASE) IN CASH 3,812,444 (10,513,981) CASH, beginning of period 1,848,328 44,854,511 CASH, end of period $5,660,772 $34,340,530 Supplemental disclosures of cash flow information Cash paid during the period for: Interest $ -- $105,817 Income taxes $913,722 $667,347 TIENS BIOTECH GROUP (USA)
'/>"/>
SOURCE Tiens Biotech Group (USA), Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results
2. Tiens Biotech Group (USA) Reports First Quarter Results
3. Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results
4. Tiens Biotech Group (USA) Reports First Quarter Results
5. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
6. Yongye Biotechnology International Retains CCG Investor Relations
7. ThirdBiotech Announces Kemeta as Newest Sponsor
8. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
9. Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Docetaxel Trial
10. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
11. China Kangtai Cactus Biotech Announces Record Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)...  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a leading ... today announced that it will release fourth quarter and ... March 10, 2015 after the close of the U.S. ... and webcast on Tuesday, March 10, 2015 at 4:30 ... results and recent corporate developments. For both ...
(Date:3/2/2015)... Outside GC, the leading provider of on-demand, in-house ... Casey as a member of the firm, further strengthening ... , Debbie has spent over 20 years in the ... North America in both legal and business capacities. ... Outside GC’s growing list of healthcare clients, with a ...
(Date:2/27/2015)... and SUMMERLAND, British Columbia , Feb. ... XON ), a leader in synthetic biology, today ... Okanagan Specialty Fruits (OSF), the pioneering agricultural company ... world,s first non-browning apple. Through the acquisition, Intrexon expands ... is more appetizing and convenient for consumers while providing ...
(Date:2/27/2015)... Nova Scotia (PRWEB) February 27, 2015 ... stage vaccine and immunotherapy company, today announced that ... its application for Fast Track designation and Phase ... vaccines, in conjunction with the mutual co-development agreement ... previously obtained Fast Track designation for the DPX-Survivac. ...
Breaking Biology Technology:Asterias Biotherapeutics to Report Fourth Quarter and Full Year 2014 Results on March 10, 2015 2Outside GC Expands Healthcare Team 2Intrexon to Acquire Okanagan Specialty Fruits 2Intrexon to Acquire Okanagan Specialty Fruits 3Intrexon to Acquire Okanagan Specialty Fruits 4Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3
... Realty Trust, Inc.,(NYSE: BMR ) today announced the tax treatment of its 2007 distributions as,follows:, ... CUSIP: 09063H107 ... Total ... Taxable Ordinary Date Date ...
... Inc.,(NYSE: BMR ) today announced it will report results ... the market closes on Thursday,February 28, 2008., Alan D. ... Officer, will host an investor conference call at 10:00,a.m. Pacific ... results and operations for the year., The call will ...
... , RICHMOND, VA, January 29 ... interview with Insmed Therapeutic Proteins President,Steve Glover ... industry is good for,patients and can stem ... from biotechnology. The American Magazine is the ...
Cached Biology Technology:BioMed Realty Trust Announces Tax Treatment of 2007 Distributions 2BioMed Realty Trust Announces Tax Treatment of 2007 Distributions 3BioMed Realty Trust To Report 2007 Fourth Quarter and Year-End Results 2Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine 2Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine 3
(Date:2/5/2015)... DIEGO , Jan. 26, 2015   Epic Sciences ... of cancer, today announced that Murali Prahalad , Ph.D., ... Personalized Medicine World Conference (PMWC) 2015: Silicon Valley, which ... Mountain View, Calif. on January 26-28, 2015. ... "CTCs Come of Age as Biomarkers." Last year, Epic Sciences ...
(Date:2/5/2015)... SAN FRANCISCO , January 28, 2015 ... Camera Market Analysis, Size And Segment Forecasts To 2020 ... The global IR camera market is expected to reach ... study by Grand View Research, Inc. IR cameras help ... injuries, and are expected to witness surging demand in ...
(Date:2/5/2015)... , Jan. 30, 2015  It is gratifying to ... and potential for genomic science as a means to ... prevention and treatment.  I was honored to participate in ... precision medicine program. Since the 1980s ... of genomics—from the first sequenced genome of a free ...
Breaking Biology News(10 mins):Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2
... , Every year the approach of flu season sets off ... are many different strains of flu and they vary from ... educated guess and tell manufacturers which variants of the flu ... works, flu-related illnesses can kill 3,000 to 49,000 Americans annually, ...
... the Polytechnic Institute of New York University (NYU-Poly) and ... carrier in their lab that is five times more ... delivery methodsreagent vectors. This novel complex is a peptide-polymer ... are used to carry DNA into cells. ...
... is a devastating illness that gradually robs sufferers of muscle ... drug available to treat the disease extends life spans by ... study published in Nature Genetics , University of Pennsylvania ... which ALS acts. Working with a powerful fruit fly model ...
Cached Biology News:Stanford researchers take a step toward developing a 'universal' flu vaccine 2Stanford researchers take a step toward developing a 'universal' flu vaccine 3Stanford researchers take a step toward developing a 'universal' flu vaccine 4Researchers engineer a hybrid 5 times more effective in delivering genetic material into cells 2Penn-led team reduces toxicity associated with Lou Gehrig's disease in animal models 2Penn-led team reduces toxicity associated with Lou Gehrig's disease in animal models 3Penn-led team reduces toxicity associated with Lou Gehrig's disease in animal models 4